ASBMB Annual Meeting

Richard Silverman to speak at ASBMB 2025

The chemist will cover drug discovery, enzyme inhibition and CNS and cancer therapies
Nicole Lynn
March 27, 2025

Richard B. Silverman, a distinguished chemist and the Patrick G. Ryan/Aon Professor at Northwestern University, will be a featured speaker at the 2025 ASBMB Annual Meeting, presenting his research in enzyme inhibition and drug discovery. Best known for inventing pregabalin, or Lyrica, Silverman has dedicated his research to designing small molecules to treat central nervous system, or CNS, disorders, including epilepsy, amyotrophic lateral sclerosis, or ALS, Alzheimer’s disease and Parkinson’s disease as well as cancer.

Richard Silverman
Richard Silverman

At ASBMB 2025, he will discuss his new work on the mechanistic drug design of small molecules to treat epilepsy, neuropathic pain and hepatocellular carcinoma.

Silverman earned his Ph.D. from Harvard University in 1974 after a two-year interruption to serve in the U.S. Army during the Vietnam War at the Walter Reed Army Institute of Research, for which he received a Commendation Medal for Meritorious Service. Following his doctoral studies, he conducted postdoctoral research at Brandeis University under Robert H. Abeles, focusing on enzyme inactivation.

In 1976, Silverman joined Northwestern University, where he was a professor of chemistry, molecular biosciences and pharmacology. His research centers on designing and developing enzyme inhibitors for CNS disorders and cancer to develop new therapeutics.

His most notable discovery, pregabalin, or Lyrica, is widely used to treat fibromyalgia, neuropathic pain, seizures and anxiety. Pregabalin works by targeting a calcium channel receptor within the CNS and decreasing neuronal excitability. Silverman donated a part of the royalties from Lyrica to Northwestern University to support and promote collaborative and interdisciplinary research in molecular diagnostics and therapeutics.

With more than 400 research publications, nearly 150 patents and multiple international awards, Silverman’s contributions to organic chemistry and drug design have been recognized worldwide. His books on enzyme mechanisms and drug design are widely used in academia and industry.

Silverman has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Inventors, the Medicinal Chemistry Hall of Fame and the Royal Society of Chemistry and has won many awards including, the Perkin Medal, the Arthur C. Cope Senior Scholar Award, the Tetrahedron Prize for Creativity in Bioorganic & Medicinal Chemistry, the Centenary Prize and the Abeles and Jencks Award for Chemistry of Biological Processes. He is a fellow of the American Chemical Society and the American Association for the Advancement of Science.

At ASBMB 2025, Silverman will present his latest research on the rational design and mechanisms of small molecules that target two enzymes: gamma-aminobutyric acid aminotransferase, as a treatment for epilepsy and neuropathic pain, and ornithine aminotransferase to treat hepatocellular carcinoma.

Pregabalin targets calcium gated ion channels in the central nervous system and reduces excitatory neurotransmitter release. This image shows a glutamate, an excitatory neurotransmitter, being transported by synaptic vesicles for release. This process is controlled by calcium gated ion channels.
Pregabalin targets calcium gated ion channels in the central nervous system and reduces excitatory neurotransmitter release. This image shows a glutamate, an excitatory neurotransmitter, being transported by synaptic vesicles for release. This process is controlled by calcium gated ion channels.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nicole Lynn

Nicole Lynn holds a Ph.D. from UCLA and is an ASBMB Today volunteer contributor.

Featured jobs

from the ASBMB career center

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Meet Lan Huang
Interview

Meet Lan Huang

May 19, 2025

Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Meet Shannon Reilly
Profile

Meet Shannon Reilly

May 12, 2025

The JLR junior associate editor discusses the role of adipocytes in obesity at Weill Cornell Medical School.

Meet Donita Brady
Interview

Meet Donita Brady

May 8, 2025

Donita Brady is an associate professor of cancer biology and an associate editor of the Journal of Biological Chemistry, who studies metalloallostery in cancer.

Glyco get-together exploring health and disease
Interview

Glyco get-together exploring health and disease

May 7, 2025

Meet the co-chairs of the 2025 ASBMB meeting on O-GlcNAcylation to be held July 10–13, 2025, in Durham, North Carolina. Learn about the latest in the field and meet families affected by diseases associated with this pathway.

ASBMB recognizes 2025 outstanding student chapter
Student Chapters

ASBMB recognizes 2025 outstanding student chapter

May 6, 2025

The Purdue group, led by Orla Hart, developed STEM outreach initiatives for low-income and minority students in Lafayette, Indiana.

ASBMB inducts 2025 honor society members
Student Chapters

ASBMB inducts 2025 honor society members

May 5, 2025

Chi Omega Lambda, which recognizes exceptional juniors and seniors pursuing degrees in the molecular life sciences, has 16 new inductees in 2025.